Back
Monopar Therapeutics Stock Price Chart
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
MNPR
Monopar Therapeutics
Last Price:
$39.20
Seasonality Move:
-13.19%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.41 | Buy |
| 20-day SMA: | 25.66 | Buy |
| 50-day SMA: | 23.12 | Buy |
| 200-day SMA: | 9.21 | Buy |
| 8-day EMA: | 29.2 | Buy |
| 20-day EMA: | 26.65 | Buy |
| 50-day EMA: | 22.7 | Buy |
| 200-day EMA: | 12.39 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.22 | Buy |
| Relative Strength Index (14 RSI): | 68.66 | Buy |
| Chaikin Money Flow: | 9701 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Monopar Therapeutics Technical Analysis
| Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 33.67 while MNPR 8-day simple moving average is 28.41, which is a Buy signal.
-
The stock price of MNPR is 33.67 while Monopar Therapeutics 20-day SMA is 25.66, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 23.12 while MNPR share price is 33.67, making it a Buy technically.
-
MNPR stock price is 33.67 and Monopar Therapeutics 200-day simple moving average is 9.21, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $33.67. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
206.9M
Price in USD:
33.67
Share Volume:
76.6K
Monopar Therapeutics 52-Week Range
52-Week High:
38.50
52-Week Low:
1.55
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 33.67 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 33.67 while MNPR 8-day exponential moving average is 29.20, which is a Buy signal.
-
The stock price of MNPR is 33.67 while Monopar Therapeutics 20-day EMA is 26.65, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 22.70 while MNPR share price is 33.67, making it a Buy technically.
-
MNPR stock price is 33.67 and Monopar Therapeutics 200-day simple moving average is 12.39, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.41 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 2.22, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 68.66, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is ( - ), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is ( - ), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.